Clinical Features of 4 Novel NOTCH3 Mutations of Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy in China.
Journal
Medical science monitor basic research
ISSN: 2325-4416
Titre abrégé: Med Sci Monit Basic Res
Pays: United States
ID NLM: 101597444
Informations de publication
Date de publication:
26 Sep 2019
26 Sep 2019
Historique:
entrez:
27
9
2019
pubmed:
27
9
2019
medline:
31
3
2020
Statut:
epublish
Résumé
BACKGROUND This study aimed to identify NOTCH3 mutations and describe the genetic and clinical features and magnetic resonance imaging results in 11 unrelated patients with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) from Henan province in China. MATERIAL AND METHODS NOTCH3 was directly sequenced in 11 unrelated patients of Chinese descent. The clinical presentations and magnetic resonance imaging features were retrospectively analyzed in the 11 index patients with a definite diagnosis. RESULTS Seven different mutations were identified in 11 unrelated patients, including 4 novel mutations (p.P167S, p.P652S, p.C709R, and p.R1100H) in China and 3 reported mutations (p.C117R, p.R578C, and p.R607C). Four novel mutations (p.P167S, p.P652S, p.C709R, and p.R1100H) were predicted to be probably pathogenic using an online pathogenicity prediction program through comprehensive analysis. Clinical presentations in symptomatic patients included stroke, cognitive decline, psychiatric disturbances, and migraine. Multiple lacunars infarcts and leukoaraiosis were detected on MRI in most symptomatic patients, while white-matter lesions were identified in the temporal pole or the external capsule in all affected patients. CONCLUSIONS The mutation spectrum of CADASIL patients from Henan province in China displayed some differences from that of those reported previously. DNA sequencing was used to diagnose all 11 patients as having CADASIL, and we found 4 novel mutations. The present results further contribute to the enrichment of NOTCH3 mutation databases.
Identifiants
pubmed: 31554780
pii: 918830
doi: 10.12659/MSMBR.918830
pmc: PMC6778411
doi:
Substances chimiques
NOTCH3 protein, human
0
Receptor, Notch3
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
199-209Références
Int J Neurosci. 2015;125(8):585-92
pubmed: 25105908
Lancet Neurol. 2009 Jul;8(7):643-53
pubmed: 19539236
J Neurol. 2015 Jan;262(1):134-41
pubmed: 25344745
Neurology. 2006 May 23;66(10):1511-6
pubmed: 16717210
Dement Geriatr Cogn Disord. 2006;21(3):162-9
pubmed: 16391479
Stroke. 1999 Jun;30(6):1230-3
pubmed: 10356105
Neurology. 2001 Mar 13;56(5):628-34
pubmed: 11245715
Eur J Neurol. 1998 May;5(3):219-233
pubmed: 10210836
J Neurol. 2009 Feb;256(2):249-55
pubmed: 19242647
Brain Pathol. 2002 Jul;12(3):371-84
pubmed: 12146805
Eur J Hum Genet. 2004 Oct;12(10):813-9
pubmed: 15378071
Lancet. 1995 Oct 7;346(8980):934-9
pubmed: 7564728
J Alzheimers Dis. 2009;17(4):787-94
pubmed: 19542611
J Neurol Neurosurg Psychiatry. 2005 May;76(5):736-8
pubmed: 15834039
Bosn J Basic Med Sci. 2015 Feb 09;15(1):1-8
pubmed: 25725137
Brain. 2009 Apr;132(Pt 4):933-9
pubmed: 19174371
J Neurol Neurosurg Psychiatry. 2011 May;82(5):534-9
pubmed: 20935329
Ann Neurol. 1998 Nov;44(5):731-9
pubmed: 9818928
Dement Neurocogn Disord. 2016 Jun;15(2):52-54
pubmed: 30906341
Stroke. 2018 Nov;49(11):2793-2800
pubmed: 30355220